Decreased Immunologic Activity: Clinical Trials

1 trial for Decreased Immunologic Activity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow Decreased Immunologic Activity: new trials by email Literature Review of Decreased Immunologic Activity trials Research Report on Decreased Immunologic Activity

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Aerosol Liposomal Cyclosporine for Chronic Rejection in Lung Transplant Recipients
Liposomal aerosol cyclosporine, standard immune suppression, oral - Disorder Related to Lung Transplantation, Bronchiolitis Obliterans
Phase 1 / Phase 2CompletedUniversity of Maryland, Baltimore212012-07-012023-06-01

Narrower conditions

Bronchiolitis Obliterans (1)  ·  Bronchiolitis Obliterans Syndrome (1)

Broader conditions

Bronchial Diseases (1)  ·  Bronchiolitis (1)  ·  Bronchitis (1)  ·  Graft vs Host Disease (1)  ·  Immune System Diseases (1)  ·  Lung Diseases (1)  ·  Lung Diseases, Obstructive (1)  ·  Organizing Pneumonia (1)  ·  Respiratory Tract Diseases (1)

Interventions

Cyclosporine (1)  ·  Sirolimus (1)  ·  Tacrolimus (1)

Sponsors

University of Maryland, Baltimore (1)

Countries

United States (1)

Top investigators

Aldo T Iacono, MD (1)